May 22, 2024

In-Vitro Toxicology Testing Market Size To Cross USD 90.42 Bn By 2032

The global in-vitro toxicology testing market size accounted for US$ 30.72 Bn in 2022 and is projected to reach around USD 90.42 Bn by 2032, growing at a CAGR of 11.4% from 2023 to 2032.

In-Vitro Toxicology Testing Market Size 2023 To 2032

Report Summary

The global in-vitro toxicology testing market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the in-vitro toxicology testing market across the globe.

A comprehensive estimate on the in-vitro toxicology testing market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of in-vitro toxicology testing during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2984

In-Vitro Toxicology Testing Market Report Scope 

Report CoverageDetails
Market Size in 2023USD 34.22 Billion
Market Size by 2032USD 90.42 Billion
Growth Rate from 2023 to 2032CAGR of 11.4%
Largest MarketNorth America
Base Year2022
Forecast Period2023 To 2032
Segments CoveredBy Technology, By Application, By Method, and By End-user
Regions CoveredNorth America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized in-vitro toxicology testing market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Genotyping Market Size To Cross USD 67.60 Bn By 2032

In-Vitro Toxicology Testing Market Players

The report includes the profiles of key in-vitro toxicology testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Major companies operating in this area

  • Charles River Laboratories International, Inc.
  • SGS S.A.
  • Merck KGaA
  • Eurofins Scientific
  • Abbott Laboratories
  • Laboratory Corporation of America Holdings
  • Evotec S.E.
  • Thermo Fisher Scientific, Inc.
  • Quest Diagnostics Incorporated
  • Agilent Technolgies, Inc.
  • Catalent, Inc.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • BioIVT
  • Gentronix
  • Labcorp Drug Development
  • Acea Biosciences Inc.
  • Cyprotex Plc
  • Ge Healthcare
  • Perkinelmer Inc.
  • Qiagen Nv
  • Biognosys Ag
  • Imquest Biosciences Inc.
  • Lonza Group Ltd.
  • Promega Corporation
  • Stemina Biomarker Discovery Inc.
  • Vistagen Therapeutics Inc.
  • Xenometrix Ag
  • MB Research Laboratories

Market Segmentation

By Technology

  • Cell Culture Technology
  • High Throughput Technology
  • Molecular Imaging
  • OMICS Technology

By Application

  • Systemic Toxicology
  • Dermal Toxicity
  • Endocrine Disruption
  • Occular Toxicity
  • Others

By Method

  • Cellular Assay
    • Live Cells
    • High Throughput / High Content Screening
    • Molecular Imaging
      • Confocal Microscopy
      • Others
    • Others
    • Fixed Cells
  • Biochemical Assay
  • In-silico
  • Ex-vivo

By End-user

  • Pharmaceutical Industry
  • Cosmetics & Household Products
  • Academic Institutes & Research Laboratories
  • Diagnostics
  • Chemicals Industry
  • Food Industry

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on In-Vitro Toxicology Testing Market 

5.1. COVID-19 Landscape: In-Vitro Toxicology Testing Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global In-Vitro Toxicology Testing Market, By Technology

8.1. In-Vitro Toxicology Testing Market, by Technology, 2023-2032

8.1.1. Cell Culture Technology

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. High Throughput Technology

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Molecular Imaging

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. OMICS Technology

8.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global In-Vitro Toxicology Testing Market, By Application

9.1. In-Vitro Toxicology Testing Market, by Application, 2023-2032

9.1.1. Systemic Toxicology

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Dermal Toxicity

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Endocrine Disruption

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Occular Toxicity

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global In-Vitro Toxicology Testing Market, By Method 

10.1. In-Vitro Toxicology Testing Market, by Method, 2023-2032

10.1.1. Cellular Assay

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Biochemical Assay

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. In-silico

10.1.3.1. Market Revenue and Forecast (2020-2032)

10.1.4. Ex-vivo

10.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global In-Vitro Toxicology Testing Market, By End-user 

11.1. In-Vitro Toxicology Testing Market, by End-user, 2023-2032

11.1.1. Pharmaceutical Industry

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Cosmetics & Household Products

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Academic Institutes & Research Laboratories

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. Diagnostics

11.1.4.1. Market Revenue and Forecast (2020-2032)

11.1.5. Chemicals Industry

11.1.5.1. Market Revenue and Forecast (2020-2032)

11.1.6. Food Industry

11.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global In-Vitro Toxicology Testing Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Technology (2020-2032)

12.1.2. Market Revenue and Forecast, by Application (2020-2032)

12.1.3. Market Revenue and Forecast, by Method (2020-2032)

12.1.4. Market Revenue and Forecast, by End-user (2020-2032)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Technology (2020-2032)

12.1.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.1.5.3. Market Revenue and Forecast, by Method (2020-2032)

12.1.5.4. Market Revenue and Forecast, by End-user (2020-2032)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Technology (2020-2032)

12.1.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.1.6.3. Market Revenue and Forecast, by Method (2020-2032)

12.1.6.4. Market Revenue and Forecast, by End-user (2020-2032)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Technology (2020-2032)

12.2.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.3. Market Revenue and Forecast, by Method (2020-2032)

12.2.4. Market Revenue and Forecast, by End-user (2020-2032)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Technology (2020-2032)

12.2.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.5.3. Market Revenue and Forecast, by Method (2020-2032)

12.2.5.4. Market Revenue and Forecast, by End-user (2020-2032)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Technology (2020-2032)

12.2.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.6.3. Market Revenue and Forecast, by Method (2020-2032)

12.2.6.4. Market Revenue and Forecast, by End-user (2020-2032)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Technology (2020-2032)

12.2.7.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.7.3. Market Revenue and Forecast, by Method (2020-2032)

12.2.7.4. Market Revenue and Forecast, by End-user (2020-2032)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Technology (2020-2032)

12.2.8.2. Market Revenue and Forecast, by Application (2020-2032)

12.2.8.3. Market Revenue and Forecast, by Method (2020-2032)

12.2.8.4. Market Revenue and Forecast, by End-user (2020-2032)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Technology (2020-2032)

12.3.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.3. Market Revenue and Forecast, by Method (2020-2032)

12.3.4. Market Revenue and Forecast, by End-user (2020-2032)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Technology (2020-2032)

12.3.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.5.3. Market Revenue and Forecast, by Method (2020-2032)

12.3.5.4. Market Revenue and Forecast, by End-user (2020-2032)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Technology (2020-2032)

12.3.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.6.3. Market Revenue and Forecast, by Method (2020-2032)

12.3.6.4. Market Revenue and Forecast, by End-user (2020-2032)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Technology (2020-2032)

12.3.7.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.7.3. Market Revenue and Forecast, by Method (2020-2032)

12.3.7.4. Market Revenue and Forecast, by End-user (2020-2032)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Technology (2020-2032)

12.3.8.2. Market Revenue and Forecast, by Application (2020-2032)

12.3.8.3. Market Revenue and Forecast, by Method (2020-2032)

12.3.8.4. Market Revenue and Forecast, by End-user (2020-2032)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Technology (2020-2032)

12.4.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.3. Market Revenue and Forecast, by Method (2020-2032)

12.4.4. Market Revenue and Forecast, by End-user (2020-2032)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Technology (2020-2032)

12.4.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.5.3. Market Revenue and Forecast, by Method (2020-2032)

12.4.5.4. Market Revenue and Forecast, by End-user (2020-2032)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Technology (2020-2032)

12.4.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.6.3. Market Revenue and Forecast, by Method (2020-2032)

12.4.6.4. Market Revenue and Forecast, by End-user (2020-2032)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Technology (2020-2032)

12.4.7.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.7.3. Market Revenue and Forecast, by Method (2020-2032)

12.4.7.4. Market Revenue and Forecast, by End-user (2020-2032)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Technology (2020-2032)

12.4.8.2. Market Revenue and Forecast, by Application (2020-2032)

12.4.8.3. Market Revenue and Forecast, by Method (2020-2032)

12.4.8.4. Market Revenue and Forecast, by End-user (2020-2032)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Technology (2020-2032)

12.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.5.3. Market Revenue and Forecast, by Method (2020-2032)

12.5.4. Market Revenue and Forecast, by End-user (2020-2032)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Technology (2020-2032)

12.5.5.2. Market Revenue and Forecast, by Application (2020-2032)

12.5.5.3. Market Revenue and Forecast, by Method (2020-2032)

12.5.5.4. Market Revenue and Forecast, by End-user (2020-2032)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Technology (2020-2032)

12.5.6.2. Market Revenue and Forecast, by Application (2020-2032)

12.5.6.3. Market Revenue and Forecast, by Method (2020-2032)

12.5.6.4. Market Revenue and Forecast, by End-user (2020-2032)

Chapter 13. Company Profiles

13.1. Charles River Laboratories International, Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. SGS S.A.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Merck KGaA

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Eurofins Scientific

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Abbott Laboratories

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Laboratory Corporation of America Holdings

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Evotec S.E.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Thermo Fisher Scientific, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Quest Diagnostics Incorporated

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Agilent Technolgies, Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com